Font Size

Privacy statement

Aim of the website

Pharmacovigilance Centre Lareb is the Dutch knowledge centre for adverse reactions to drugs and other health products. Adverse drug reactions (ADRs) can be reported using the reporting form on this website or via the “Bijwerking” app. Each report of an ADR is carefully analyzed and recorded in a central database. Reports are anonymously displayed on this website and the app. In addition, knowledge about ADRs and Lareb is distributed via this website and the app.

ADR reports

Personal information that is asked for on the reporting form is handled according to the General Data Protection Regulation (GDPR) and the general privacy regulation of Pharmacovigilance Centre Lareb. The general privacy regulation of Pharmacovigilance Centre Lareb is only available in Dutch. Personal information that is asked for is used for the registration of the ADR report and communication with the reporter. In order to detect duplicate reports, Pharmacovigilance Centre Lareb checks if the case already has been reported by using the patient’s date of birth and gender. Reporters may be approached for extra information about the case. In addition, reporters may be asked to fill in a questionnaire about the quality of the service of Pharmacovigilance Centre Lareb. The results of this questionnaire are exclusively shared with the management of Pharmacovigilance Centre Lareb.

Personal information

The following personal information is collected:

From the reporter:

  • E-mail address (for registration and correspondence between reporter and Pharmacovigilance Centre Lareb)
  • 4 digits postal code (for mapping of distribution of reporting within the Netherlands; reporting of postal code is not mandatory)
  • Phone number (for correspondence between reporter and Pharmacovigilance Centre Lareb; reporting of phone number is not mandatory)
  • Last name (reporting of last name is not mandatory)

From the patient who experienced the ADR:

  • Gender
  • Date of birth
  • Drug use and indication
  • Medical information
  • Experienced adverse drug reaction(s)

 

Sharing with third parties

Reported ADRs are shared, without personal information of the reporter and patient, (with the exception of the patient’s age and gender) to the Netherlands Medicine Evaluation Board (CBG), the European Medicines Agency (EMA), the World Health Organization (WHO) and the marketing authorization holders (MAHs) of the suspected drug. The aim of forwarding the reports to these third parties is to monitor the safety of drugs nationally as well as internationally.

In addition, anonymised reports are incidentally shared with the Federation of Dutch Thrombosis Services (FNT), the Health and Youth Care Inspectorate (IGJ), the Netherlands Food and Consumer Product Safety Authority (NVWA), Dutch Pharmacy Association (KNMP), the National Institute for Public Health and the Environment (RIVM), Foundation for Patient Safety (PvP) and Eurocat (researchgroups of the University Medical Centre of Groningen).

Description of automatized data collection

All data collected on the reporting form is automatically processed and stored in the database of Pharmacovigilance Centre Lareb. This is a shielded database; only authorised staff members of the Pharmacovigilance Centre Lareb have access to this database.

Right to access, correction and erasure

At any time, reporters can make a request to withdraw their consent, or to access, correct or erase their personal data. Requests can be sent by e-mail to info@lareb.nl . Lareb will follow up your request within four weeks.

Security

Pharmacovigilance Centre Lareb has undertaken technical security measures to protect personal data. All data collected by the form on the website, is secured by a Secure Sockets Layer (SSL). This protocol secures the connection between your computer and the website and ensures that all data is shielded during transport and cannot be read by third parties. You can check this in the browser bar, which shows that the website address begins with https://

All information in the reports are only accessible to staff members of Pharmacovigilance Centre Lareb who have specific login codes.

The website

Use of cookies

A cookie is a small file that is sent by web servers and to your browser and stored on the hard drive of your computer. These cookies help improve the website’s usability and your experience when you visit our website Pharmacovigilance Centre Lareb uses functional and analytical cookies on its website. Functional cookies (cookies that are necessary to make the website operate) and analytical cookies, that have little or no impact on privacy, are always placed when you visit our website. The purpose of a functional cookie is to save the current scroll position. This expires after a session.

On this website, Pharmacovigilance Centre Lareb uses Google Analytics, a web analytics service provided by Google Inc. (Google). We use this service to track how visitors use the website, with the aim of improving the website. The Netherlands Pharmacovigilance Centre Lareb has signed a data processing agreement with Google and selected ‘masking the last octet of your IP address’. The 'data sharing' is off and the Netherlands Pharmacovigilance Centre Lareb does not use other Google services in conjunction with Google Analytics cookies on this website..

Using links

You should be aware that the Netherlands Pharmacovigilance Centre Lareb is not responsible for the privacy policy of websites of third parties, which are accessible via a link on our website. We recommend you to read the privacy statement and disclaimer on the websites of third parties. You can see that you are no longer on our website when the URL (website address) has changed.

Company information

The collected data are processed by:

Netherlands Pharmacovigilance Centre Lareb
Goudsbloemvallei 7
5237 MH 's-Hertogenbosch
The Netherlands
Phone: +31 73 64 69 700
E-mail: info@lareb.nl

Release date: 23-10-2018

 

Subscribe to our newsletter